We analyzed the gene expression levels of 12 hub genes with clinical tumor stages and found that TNFSF13B, CASP5 and GJB6 correlated positively with tumor stages, while FREM1 showed negative associations with tumor stages. The gene discussed is TNFSF13B; the disease is neoplasm.